Neuronetics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-30.19	-37.16	-31.19	-27.45	-29.04	-24.1	-16.06	-11.23
Depreciation & Amortization	2.01	1.65	1.06	0.94	1.07	0.88	0.6	0.67
Share-Based Compensation	7.32	8.75	7.87	4.4	3.43	1.74	0.5	0.16
Other Operating Activities	-11.17	-3.97	-5.72	-6.28	-5.94	0.88	3.82	1.86
Operating Cash Flow	-32.04	-30.74	-27.98	-28.39	-30.48	-20.59	-11.14	-8.54
Capital Expenditures	-2.37	-3.27	-2.35	-0.73	-0.81	-1.01	-0.59	-0.32
Change in Investments	1.05	10	-7.49	0	0	0	0	0
Investing Cash Flow	-1.32	6.73	-9.84	-0.73	-0.81	-1.01	-0.59	-0.32
Share Issuance / Repurchase	0	0.3	83.01	0.69	2.42	97.04	0.04	0.07
Debt Issued / Paid	22.7	-0.09	0	1.68	0	0	8.99	4.83
Other Financing Activities	-	-	-	-	-	-	14.83	-
Financing Cash Flow	22.7	0.21	83.01	2.37	2.42	97.04	23.85	4.9
Net Cash Flow	-10.66	-23.8	45.18	-26.75	-28.88	75.44	12.11	-3.97
Free Cash Flow	-34.41	-34.01	-30.34	-29.12	-31.3	-21.6	-11.74	-8.87
Free Cash Flow Margin	-48.22%	-52.15%	-54.85%	-59.13%	-49.95%	-40.93%	-29.03%	-25.90%
Free Cash Flow Per Share	-1.20	-1.26	-1.19	-1.55	-1.70	-2.41	-63.11	-60.72

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).